• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL - DIABETES CARE BD MICROFINE¿ INSULIN SYRINGE; INSULIN SYRINGE WITH NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL - DIABETES CARE BD MICROFINE¿ INSULIN SYRINGE; INSULIN SYRINGE WITH NEEDLE Back to Search Results
Catalog Number 324824
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/05/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation and/or device history review, a supplemental report will be filed.
 
Event Description
It was reported that a bd microfine¿ insulin syringe had gray discoloration at syringe tip in front of protective cap.
 
Manufacturer Narrative
H.6.Investigation summary: customer returned (8) loose 1/2cc, 8mm syringes.Customer states that there is gray discoloration at syringe tip in front of protective cap.All returned syringes were examined under the microscope and all exhibited dark material smeared on the outer surface of the barrel ranging from the 0-10 unit markings.A small portion of this material was removed from the sample and prepared for ftir spectral analysis.The spectral analysis shows that this material is most likely smeared ink.A review of the device history record was completed for batch# 8113592.All inspections and challenges were performed per the applicable operations qc specifications.There was one (1) notification [200753325] noted that did not pertain to the complaint.Based on the samples / photo(s) received the investigation concluded: confirmed: bd was able to duplicate or confirm the customer¿s indicated failure (smeared ink).Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Based on the investigation, no capa is required at this time.Possible root cause is attributed to pad swelling on the mandril during the printing process.As the pads are used, they gradually swell and can cause this type of "smear" or "smudge affect.A problem solving team has been tasked with improving print quality on all production lines within the plant.The team is systematically assessing and addressing each printer individually for improvements.
 
Event Description
It was reported that a bd microfine¿ insulin syringe had gray discoloration at syringe tip in front of protective cap.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MICROFINE¿ INSULIN SYRINGE
Type of Device
INSULIN SYRINGE WITH NEEDLE
Manufacturer (Section D)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
MDR Report Key8191610
MDR Text Key131334956
Report Number1920898-2018-00971
Device Sequence Number1
Product Code FMF
UDI-Device Identifier00382904824013
UDI-Public382904824013
Combination Product (y/n)N
PMA/PMN Number
K941657
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 01/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2023
Device Catalogue Number324824
Device Lot Number8113592
Initial Date Manufacturer Received 12/07/2018
Initial Date FDA Received12/21/2018
Supplement Dates Manufacturer Received12/07/2018
Supplement Dates FDA Received01/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-